Setup and characterization of a human head and neck squamous cell carcinoma xenograft model in nude rats

被引:25
作者
Bao, Ande
Phillips, William T.
Goins, Beth
McGuff, Howard S.
Zheng, Xiangpeng
Woolley, F. Ross
Natarajan, Mohan
Santoyo, Cristina
Miller, Frank R.
Otto, Randal A.
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Otolaryngol Head & Neck Surg, San Antonio, TX 78229 USA
[2] Univ Texas, Hlth Sci Ctr, Dept Radiol, San Antonio, TX 78229 USA
[3] Univ Texas, Hlth Sci Ctr, Dept Pathol, San Antonio, TX 78229 USA
[4] Univ Texas, Hlth Sci Ctr, Dept Radiat Oncol, San Antonio, TX 78229 USA
关键词
D O I
10.1016/j.otohns.2006.06.1257
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE: To develop and characterize a new head and neck cancer animal model. STUDY DESIGN: A human head and neck squamous cell carcinoma (HNSCC) xenograft model in nude rats was established via subcutaneous inoculation of a human-origin HNSCC cell line, SCC-4. The tumor was evaluated for growth characteristics, pathologic features by hematoxylin-eosin (HE) staining, and immunohistochemistry of epidermal growth factor receptor (EGFR). 2-[F-18] fluoro-2-deoxy-D-glucose (F-18-FDG) positron emission tomography (PET) imaging characteristics were studied too. RESULTS: A new HNSCC animal model was successfully established. Tumor sizes reached about 1 cm(3) on day 15 after tumor cell inoculation. HE staining pathology has confirmed that this tumor is a typical SCC. EGFR immunohistochemistry demonstrated this tumor model to be strongly EGFR positive. F-18-FDG PET study has shown that F-18-FDG accumulated in tumors. CONCLUSIONS: This study has demonstrated that this tumor model is an appropriate HNSCC tumor model for animal studies on HNSCC. (c) 2006 American Academy of Otolaryngology-Head and Neck Surgery Foundation. All rights reserved.
引用
收藏
页码:853 / 857
页数:5
相关论文
共 18 条
[1]   Potential use of drug carried-liposomes for cancer therapy via direct intratumoral injection [J].
Bao, Ande ;
Phillips, William T. ;
Goins, Beth ;
Zheng, Xiangpeng ;
Sabour, Sarmad ;
Natarajan, Mohan ;
Woolley, F. Ross ;
Zavaleta, Cristina ;
Otto, Randal A. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 316 (1-2) :162-169
[2]  
Dearling JLJ, 2004, J NUCL MED, V45, P101
[3]   Radiation dose estimate in small animal SPECT and PET [J].
Funk, T ;
Sun, MS ;
Hasegawa, BH .
MEDICAL PHYSICS, 2004, 31 (09) :2680-2686
[4]   FDG-PET. A possible prognostic factor in head and neck cancer [J].
Halfpenny, W ;
Hain, SF ;
Biassoni, L ;
Maisey, MN ;
Sherman, JA ;
McGurk, M .
BRITISH JOURNAL OF CANCER, 2002, 86 (04) :512-516
[5]   High interstitial fluid pressure -: An obstacle in cancer therapy [J].
Heldin, CH ;
Rubin, K ;
Pietras, K ;
Östman, A .
NATURE REVIEWS CANCER, 2004, 4 (10) :806-813
[6]  
JAIN RK, 1988, CANCER RES, V48, P7022
[7]  
Kostakoglu L, 2004, J NUCL MED, V45, P56
[8]   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib [J].
Lynch, TJ ;
Bell, DW ;
Sordella, R ;
Gurubhagavatula, S ;
Okimoto, RA ;
Brannigan, BW ;
Harris, PL ;
Haserlat, SM ;
Supko, JG ;
Haluska, FG ;
Louis, DN ;
Christiani, DC ;
Settleman, J ;
Haber, DA .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) :2129-2139
[9]   Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer [J].
Mendelsohn, J ;
Baselga, J .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (14) :2787-2799
[10]   Positron emission tomography in the management of unknown primary head and neck carcinoma [J].
Miller, FR ;
Hussey, D ;
Beeram, M ;
Eng, T ;
McGuff, HS ;
Otto, RA .
ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2005, 131 (07) :626-629